Status:
RECRUITING
Implementation of Prevention and Intervention of Maternal Perinatal Depression to Strengthen Maternal and Child Health
Lead Sponsor:
Katri Räikkönen
Collaborating Sponsors:
Helsinki University Central Hospital
Conditions:
Perinatal Depression
Eligibility:
FEMALE
Phase:
NA
Brief Summary
IMPRINT strengthens maternal and child health by screening, treating and preventing maternal perinatal depression, the most common complication of pregnancy and the child's first 1000 days. It is asso...
Eligibility Criteria
Inclusion
- EPDS screen result of 10 or more
- Agreed to be invited for the intervention during the screening phase
Exclusion
- Active suicidality
- Presence of severe mental disorder
- Concurrent use of psychotropic medication / concurrently under psychosocial treatment for mental disorder
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04069091
Start Date
January 1 2020
End Date
December 31 2027
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Helsinki
Helsinki, Uusimaa, Finland, 00014